TB-500 and BPC-157 (both available in Spartans research catalog) have been studied for tissue repair via different mechanisms (thymosin beta-4 and angiogenic/cytoprotective pathways respectively)
The anti-inflammatory pathways modulated by GLP-1 receptor activation (NF-kB suppression, macrophage polarization, Treg enhancement) are largely distinct from the pathways targeted by: Methotrexate: Folate metabolism disruption, different anti-inflammatory pathway TNF inhibitors (adalimumab, etanercept): Direct TNF blockade, whereas GLP-1 reduces TNF production upstream IL-6 inhibitors (tocilizumab): Receptor-level blockade, while GLP-1 reduces IL-6 production JAK inhibitors (tofacitinib, baricitinib): Different signaling pathway entirely Corticosteroids: Broad immunosuppression, while GLP-1 is immunomodulatory This pathway complementarity is why additive benefit is biologically plausible
The Tn Pharma R&D Team chose to take advantage of this innovative technology by making the Liposomal Glutathione 30 Vegetable Caps formula because, contrary to the findings of some studies, glutathione appears to be poorly available orally (unfavorable pharmacokinetics)
, 15 , 695-705, Rudenko, A
